Summary: Exploitation through misrepresentation of the facts or concealment of the purposes of the exploiter.
Publications214 found, 100 shown here
- Whistleblower-initiated enforcement actions against health care fraud and abuse in the United States, 1996 to 2005Aaron S Kesselheim
Brigham and Women s Hospital, Boston, Massachusetts, USA
Ann Intern Med 149:342-9. 2008Federal regulators have aggressively prosecuted health care fraud since the early 1990s, leading to billions of dollars in financial recoveries...
- Retractions in the scientific literature: do authors deliberately commit research fraud?R Grant Steen
Medical Communications Consultants LLC, 103 Van Doren Place, Chapel Hill, NC 27517, USA
J Med Ethics 37:113-7. 2011Papers retracted for fraud (data fabrication or data falsification) may represent a deliberate effort to deceive, a motivation fundamentally different from papers retracted for error...
- The global threat of counterfeit drugs: why industry and governments must communicate the dangersRobert Cockburn
The Times, London, United Kingdom
PLoS Med 2:e100. 2005
- Misinformation in the medical literature: what role do error and fraud play?R Grant Steen
Medical Communications Consultants, LLC, 103 Van Doren Place, Chapel Hill, NC 27517, USA
J Med Ethics 37:498-503. 2011..Still, one-quarter of retracted papers are fraudulent, and misinformation may also arise through fraud. This paper hypothesises that error and fraud are the main sources of misinformation and that error is more common ..
- Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometryCamilla Ricci
Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK
Anal Chim Acta 623:178-86. 2008..The applicability of a compact and robust portable Raman spectrometer (TruScan) for the in situ chemical identification of counterfeit tablets is reported...
- Off-label or off-limits?Mark Ratner
Nat Biotechnol 26:867-75. 2008
- Detecting hospital fraud and claim abuse through diabetic outpatient servicesFen May Liou
Graduate Institute of Business Management, Yuanpei University Hsinchu, 306, Yuanpei St, Hsin Chu 300, Taiwan
Health Care Manag Sci 11:353-8. 2008..While all three are quite accurate, the classification tree model performs the best with an overall correct identification rate of 99%. It is followed by the neural network (96%) and the logistic regression model (92%)...
- Health care fraud and abuseP E Kalb
Sidley and Austin, Washington, DC, USA
JAMA 282:1163-8. 1999In recent years, health care fraud and abuse have become major issues, in part because of the rising cost of health care, industry consolidation, the emergence of private "whistle-blowers," and a change in the concept of fraud to include ..
- Science fraud: from patchwork mouse to patchwork dataGerald Weissmann
FASEB J 20:587-90. 2006
- WHO launches taskforce to fight counterfeit drugsWilliam Burns
Bull World Health Organ 84:689-90. 2006
- Counterfeit pharmaceuticals: current status and future projectionsAlbert I Wertheimer
Center for Pharmaceutical Health Services Research, Temple University, Philadelphia, PA 19140, USA
J Am Pharm Assoc (2003) 43:710-7; quiz 717-8. 2003..To examine the problem of counterfeit drugs and its effects around the world, to consider the likely directions the problem will take, and to propose options for controlling or mitigating the problem...
- Manslaughter by fake artesunate in Asia--will Africa be next?Paul N Newton
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom
PLoS Med 3:e197. 2006
- Counterfeit pharmaceuticals: murder by medicinePeter Aldhous
Nature 434:132-6. 2005
- The effects of the fraud and abuse enforcement program under the National Health Insurance program in KoreaHeeChung Kang
Health Insurance Review and Assessment Policy Institute, Health Insurance Review and Assessment Service, Republic of Korea
Health Policy 95:41-9. 2010To examine the general deterrence effect of the Korean government's fraud and abuse enforcement program on medical clinics in the country...
- Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in CambodiaMohiuddin Hussain Khan
Department of Drug Management and Policy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan
Trop Med Int Health 15:639-44. 2010..To assess the prevalence of counterfeit anthelminthic medicines in Cambodia, and to determine influential factors...
- Detecting Medicare abuseDavid Becker
University of California, Berkeley, CA 94720, USA
J Health Econ 24:189-210. 2005..claims data linked with social security death records, hospital characteristics, and state/year-level anti-fraud enforcement efforts...
- Tackling corruption in the pharmaceutical systems worldwide with courage and convictionJ C Cohen
Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada
Clin Pharmacol Ther 81:445-9. 2007..are caused by a number of variables including poverty, high drug prices, poor health infrastructure, and fraud and corruption--the latter being the subject of this article...
- The role of biostatistics in the prevention, detection and treatment of fraud in clinical trialsM Buyse
International Institute for Drug Development, Brussels, and Limburgs Universitair Centrum, Diepenbeek, Belgium
Stat Med 18:3435-51. 1999Recent cases of fraud in clinical trials have attracted considerable media attention, but relatively little reaction from the biostatistical community...
- Food forensics: using DNA technology to combat misdescription and fraudMark Woolfe
Food Labelling and Standards Division, Food Standards Agency, Aviation House, 125 Kingsway, London, WC2B 6NH, UK
Trends Biotechnol 22:222-6. 2004
- Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formationLeonard Nyadong
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, USA
Anal Chem 79:2150-7. 2007..Of particular concern was the positive detection of artesunate traces in the surface of one of the samples, which we quantified with standard chromatographic techniques...
- Counterfeit drugsPaul M Rudolf
Food and Drug Administration, Rockville, MD, USA
N Engl J Med 350:1384-6. 2004
- Counterfeit artesunate antimalarials in southeast AsiaPaul N Newton
Lancet 362:169. 2003
- Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarialsA M Dondorp
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Trop Med Int Health 9:1241-6. 2004..To assess the prevalence of counterfeit antimalarial drugs in Southeast (SE) Asia...
- Antidepressants are sold as antiretrovirals in DR CongoKhabir Ahmad
Lancet 363:713. 2004
- Substandard medicines in resource-poor settings: a problem that can no longer be ignoredJ M Caudron
Medecins Sans Frontieres, Geneva, Switzerland, and AEDES Fondation, Brussels, Belgium
Trop Med Int Health 13:1062-72. 2008..Governments in rich countries should not tolerate the export of substandard pharmaceutical products to poor countries, while developing country governments should improve their ability to detect substandard medicines...
- Emerging non-invasive Raman methods in process control and forensic applicationsNeil A MacLeod
Central Laser Facility, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0QX, UK
Pharm Res 25:2205-15. 2008....
- Scientific misconduct. Researcher faces prison for fraud in NIH grant applications and papersEli Kintisch
Science 307:1851. 2005
- Human cloning and embryonic stem cell research after Seoul: examining exploitation, fraud and ethical problems in the research. Testimony of Richard M. DoerflingerRichard M Doerflinger
Natl Cathol Bioeth Q 6:339-50. 2006
- Counterfeit and substandard antimalarial drugs in CambodiaC T Lon
National Center for Parasitology, Entomology and Malaria Control, 372 Boulevard Monivong, Phnom Penh, Cambodia
Trans R Soc Trop Med Hyg 100:1019-24. 2006..Appropriate strategies need to be developed and implemented by relevant government agencies and stakeholders to strengthen drug quality assurance and control systems in the country...
- Murder by fake drugsPaul N Newton
BMJ 324:800-1. 2002
- Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemicAlbert I Wertheimer
Temple University, School of Pharmacy, 3307 No Broad Street, Philadelphia, PA 19140, USA
Res Social Adm Pharm 5:4-16. 2009..Counterfeiting and the sale of substandard pharmaceutical products can no longer be ignored. At 10% of global trade, counterfeiting is affecting many countries, causing serious downstream expenses and resource shortages...
- Fraud, errors and gamesmanship in experimental toxicologyIain F H Purchase
University of Manchester, Oxford Road, Manchester M13 9PT, UK
Toxicology 202:1-20. 2004..The main casualty from fraud, errors and gamesmanship is the perceived status of science itself...
- India agrees to help Nigeria tackle the import of fake drugsAbiodun Raufu
BMJ 326:1234. 2003
- Drug regulators study global treaty to tackle counterfeit drugsLiza Gibson
BMJ 328:486. 2004
- A right to no meaningful review under the due process clause: the aftermath of judicial deference to the federal administrative agenciesRuqaiijah A Yearby
Loyola University Chicago School of Law, USA
Health Matrix Clevel 16:723-83. 2006
- Fixing past mistakes. Answers to questions about reviews, refunds, disclosuresT Jeffrey Fitzgerald
Faegre and Benson, LLP, Denver, USA
MGMA Connex 3:38-43, 1. 2003..Its response has a significant impact on how the charges are resolved. A group and its providers can come under fraud and abuse investigations, whistle-blower allegations and Medicare payment reviews...
- Tenet, HealthSouth clear some legal woesVince Galloro
Mod Healthc 36:17. 2006
- Secondary payer predicament. U.S. Justice Department probes insurers that billed Medicare as primary payerMark Taylor
Mod Healthc 33:16-7. 2003
- HealthSouth avoids chargesJoseph Mantone
Mod Healthc 36:7. 2006
- Beyond the anti-kickback statute: new entities, new theories in healthcare fraud prosecutionsJames G Sheehan
Saint Louis University School of Law, USA
J Health Law 40:167-203. 2007The authors analyze existing and developing trends in healthcare fraud litigation. They first review the traditional use of the Medicare-Medicaid Anti-Kickback Statute to prosecute such fraudulent activity...
- Justice sues ex-lawyer for TenetVince Galloro
Mod Healthc 37:16. 2007
- Obtaining advance beneficiary notices for Medicare physician providersDarren Carter
Provistas, Incorporated, 12 Dongan Place, Suite 203, New York, NY 10040 1592, USA
J Med Pract Manage 19:10-8. 2003..The author also presents special applications of the ABN regulations as they apply to the EMTALA rules, anti-kickback, and other statutes. Samples of the official ABN forms are illustrated...
- Identifying barriers to billing complianceDaniel P Lorence
Pennsylvania State University, University Park, PA, USA
J Health Care Finance 30:49-64. 2003Programs designed toward the control of health care fraud are leading to increasingly aggressive enforcement and prosecutorial efforts by federal regulators, related to over-reimbursement for service providers...
- Being aware of fraud and abuse is still critically importantCarolyn J Humphrey
Home Healthc Nurse 21:507. 2003
- Observation services present compliance challengesSue Prophet-Bowman
J AHIMA 74:60-5. 2003
- Managing board relationships in tough timesKimberly Commins
Hall, Render, Killian, Heath and Lyman, PSC, Troy, USA
Mich Health Hosp 39:56-7. 2003....
- OASIS coding, your license, and your reputationElizabeth A Madigan
Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH 44106 4904, USA
Home Healthc Nurse 24:190. 2006
- Fraud and fiduciary liabilityBrian Ray Hodge
Lacquer, Urban, Clifford and Hodge, LLP, Pasadena, California, USA
Empl Benefits J 28:53-61. 2003..brokers and promoters selling fraudulent policies; plans large enough to be self-insured face greater risks of fraud by providers and participants misrepresenting claims...
- Picking up the tab. Healthcare chains put the past behind them, resolving past unpleasantries in order to make a clean start in the new yearVince Galloro
Mod Healthc 35:6-7, 1. 2005..Peter Urbanowicz, left, said his company's moves show "the real progress we are making to put our legal challenges ... behind us"...
- Are you of good report?Shelley R Slade
Vogel and Slade, LLP, Washington, DC, USA
Healthc Financ Manage 58:38-40. 2004..Past Medicare credit balance reports may come back to haunt you as current federal enforcement activities indicate they could easily fall under False Claims Act scrutiny...
- Why should your practice perform compliance audits based on the latest OIG Work Plan?Marilyn Hammon
J Okla State Med Assoc 98:95-7. 2005....
- Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecutionDavid M Studdert
Harvard School of Public Health, Boston, USA
N Engl J Med 351:1891-900. 2004
- False claims recoveries down. Experts: 2006 figure understates feds' determinationGregg Blesch
Mod Healthc 37:16. 2007
- The False Claims Act: the courts move toward a rule of reasonMichael M Mustokoff
Partner, Duane Morris, LLP, One Liberty Place, Philadelphia, PA 19103 7396, USA
J Med Pract Manage 20:317-22. 2005..It indicates the limitations that are imposed on prosecutors, as well as the liability that providers do incur under current statues...
- The False Claims Acts & Qui Tam lawsuitsHarvey M Tettlebaum
Husch and Eppenberger LLC, Jefferson City, Missouri, USA
Mo Med 104:466-9. 2007
- Physician joint ventures: new opportunities and risksJeremy N Miller
Miller Health Law Group, APLC, 2029 Century Park East, Third Floor, Los Angeles, CA 90067, USA
J Med Pract Manage 19:292-5. 2004..These regulations have now been clarified leading to a resurgent interest in these arrangements. This article outlines the business principles, control issues, legal setting, and the various modalities for joint venturing...
- When Medicare auditors decide it's time for a check-upBruce A Levy
N J Med 99:33-7. 2002
- Apria, Tenet settle casesJoseph Mantone
Mod Healthc 35:18. 2005
- The deficit reduction act of 2005: policy, politics, and impact on radiologistsJames W Moser
American College of Radiology, Reston, VA 20191, USA
J Am Coll Radiol 3:744-50. 2006..Although the DRA cuts payments for certain imaging services, it does nothing to control utilization, which is the prime mover driving spending...
- Make sense of wound care billing: turn your cents into reimbursement dollarsDeanna M Vargo
Department of Ambulatory Care Wound Care, Summa Health System, Barberton Citizens Hospital, Barberton, Ohio 44203, USA
J Wound Ostomy Continence Nurs 35:186-96; quiz 197-8. 2008..Therefore, investing the time to check the site for the latest updates can make a critical difference in your success with reimbursement for wound care services...
- Ethical lawyering in the gray areas: health care fraud and abuseJoan H Krause
University of Houston Law Center and Health Law and Policy Institute, Houston, TX, USA
J Law Med Ethics 34:121-5. 2006
- Blaming the messenger. Ernst & Young under fire for alleged bad billing adviceMark Taylor
Mod Healthc 34:18-9. 2004
- Tenet wades through legal mess. $215 million settlement reached; jury deliberatesVince Galloro
Mod Healthc 36:10. 2006
- False Claims Act applies to local governmentG Christopher Kelly
Emerg Med Serv 32:114. 2003
- Crafting risk-free vendor contractsAri J Markenson
Epstein Becker and Green, New York City, USA
Provider 29:75-7. 2003
- Florida couple admits using phony treatment to attract clientsCarol Lewis
FDA Consum 36:38-9. 2002
- Regional variation in medical systems data: influences on upcodingDaniel P Lorence
Department of Health Policy and Administration, The Pennsylvania State University, University Park 16802, USA
J Med Syst 26:369-81. 2002..We find significant variation in influence across practice settings and managed care markets. Ramifications for reimbursement assessment are discussed...
- Echoing down from Wall St. Proposed new accounting standards could bring new guidelines for not-for-profits; conflicts between boards, CFOs could result. Merck, Allegheny, HBO & CoMary Chris Jaklevic
Mod Healthc 32:8-9, 16, 3. 2002..The healthcare industry, which has been trying to scrub clean its own image, is no stranger to the kind of scandals plaguing other industries...
- Trustee workbook 3. Effective governance after Enron and AHERFJames E Orlikoff
Trustee 55:15-8. 2002..The Enron bankruptcy will certainly result in lawsuits against its board and directors and has embarrassed board members profoundly...
- The emperor has no clothes: examining the employee exception to the anti-referral lawsS O Scheutzow
Ulmer and Berne LLP, Cleveland, OH, USA
J Health Law 34:21-45. 2001..Consequently, she asserts that this exception should be repealed...
- False Claims Act: failure to seek legal advice not a violation of the FCAJeanne Cavanaugh
J Law Med Ethics 30:318-9. 2002
- Using the OIG model compliance programs to fight fraudJeffrey A Lovitky
Ahern and Associates, Department of Health Systems Management, Rush University, Chicago, Illinois, USA
Healthc Financ Manage 56:64-8. 2002..Using these models as guides, healthcare organizations should be better able to avoid the possibility of fraud and abuse within their organizations.
- The government, the legislature and the judiciary--working towards remedying the problems with the civil False Claims Act: where do we go from here?R A McClain
Piper, Marbury, Rudnick and Wolfe, Chicago, USA
Ann Health Law 10:191-243. 2001..The article explores the use and effectiveness of the False Claims Act to target fraud and other abuses in the health care system...
- Payment due. Report: CMS slacker for not collecting millionsMark Taylor
Mod Healthc 32:4, 14. 2002
- "This might sting a bit": policing skin care in nursing facilities by litigating fraudMichael Stockham
Cornell Law Rev 87:1041-77. 2002
- Are you committing health care fraud under the False Claims Act? The answer may not be as simple as you thinkMichael K Goldberg
Goldberg and Frankenstein, LLC, 222 South Riverside Plaza, Suite 810, Chicago, IL 60606, USA
J Med Pract Manage 17:206-9. 2002Health care fraud has a significant financial effect on the operations of the American health care system...
- Corporate integrity agreements: making the best of a tough situationRobert B Ramsey
Healthcare Group of Buchanan Ingersoil, Pittsburgh, Pennsylvania, USA
Healthc Financ Manage 56:58-62. 2002..are entering into corporate integrity agreements as part of settlements with the Federal government in fraud-and-abuse cases...
- The impact of gaining provider status in the Medicare program. What all dietetics professionals need to knowEllen Pritchett
J Am Diet Assoc 102:480-2. 2002
- Nursing homes face quality-of-care scrutiny under the False Claims ActB S Landsberg
Litigation and Employment Business Unit, Manatt, Phelps and Phillips, LLP, Los Angeles, California, USA
Healthc Financ Manage 55:54-8. 2001..In a recent case, however, a Federal judge refused to grant the defendant facility's motion to dismiss and permitted the government's case to proceed...
- Healthcare fraud probes have hospitals ahead of the gameVince Galloro
Mod Healthc 32:8-9. 2002
- Quality-of-care issues can create False Claims Act exposureShelley R Slade
Healthc Financ Manage 56:78-80. 2002..Providers can be fined triple the government's payment if they are found in violation of the False Claims Act. Providers should be aware of knowing violations of quality standards that could lead to False Claims Act exposure...
- The other shoe drops. Barbakow, already set to lose chairman's seat, out as Tenet's CEO; shareholders, analyst call for outsider as his replacementVince Galloro
Mod Healthc 33:4-5, 16, 1. 2003..stepped down last week from the company he headed during a period of glowing prosperity. But as he departs, Tenet is surrounded by a tempest similar to the one that led to his hiring...
- CMS rebuked on DME. Inspector general report finds 28.9% error rate on claimsGregg Blesch
Mod Healthc 38:20. 2008
- The uncivil war against health care fraud. Who will be excluded next? Part. IMarc E Overlock
Tennessee Medical Foundation, USA
Tenn Med 96:227-8. 2003
- Clinical trials face heightened scrutiny as science and commerce appear to mergeAlvin J Lorman
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, USA
J Biolaw Bus 4:23-32. 2001..The risk of increased government involvement includes criminal prosecution of physicians for failing to follow the rules, as an innovative case in California demonstrates...
- Monitoring improper Medicare payments. New CMS programs build on OIG methods to report errorsRita A Scichilone
J AHIMA 74:70-3. 2003
- Fraud flurry. No connection seen in recent moves by governmentMark Taylor
Mod Healthc 33:20, 22. 2003
- Consultant relationships may pose liability riskGabriel L Imperato
Healthc Financ Manage 57:72-5. 2003..Providers that contract with attorneys, accountants, payment experts, and/or other third-party consultants need to monitor these relationships on an ongoing basis...
- Medicare cost controls and program compliance: the rationale of physician claims editsDarren Carter
J Med Pract Manage 18:115-9. 2002..Many resources are available to aid physicians, including computerized tools, new CMS initiatives, and Internet materials...
- A question of integrity. Federal prosecutors question Tenet's compliance with integrity agreement in a $323 million False Claims Act lawsuitMark Taylor
Mod Healthc 33:6-7, 16, 1. 2003..The False Claims Act suit alleges Tenet illegally submitted thousands of false claims to maximize revenue. Lawyer Michael Ruggio says Tenet's troubles are far from over...
- Medicare fraud-busters target patient transfer reportingStephen G Sozio
Trustee 55:46-7. 2002
- Achieving compliance with medical call centersWilliam D Darling
Healthc Financ Manage 56:82-6. 2002..A provider may not escape responsibility for compliance by contracting with call-center vendors. Providers and call-center vendors should work together to understand and comply with relevant statutes...
- Practical considerations for conducting effective billing auditsRobert F Bacon
Office of Billing Compliance, University of Pennsylvania, Health System, Philadelphia, Pennsylvania, USA
Healthc Financ Manage 56:36-9. 2002..regulations, especially with the increased vigilance by the HHS Office of Inspector General (OIG) in investigating fraud and abuse...
- Physicians' reliance on specialists, therapists, and vendors when prescribing therapies and durable medical equipment for children with special health care needsR C Sneed
Department of Pediatrics, Children s Rehabilitation Center, University of Mississippi Medical Center, Jackson, MS 39216 4505, USA
Pediatrics 107:1283-90. 2001..To protect themselves and their patients from fraud and inappropriate prescriptions and medical management, pediatricians must become increasingly conscientious about ..
- The role of the FDA in the effort against AIDSF E Young
Office of Public Affairs, Rockville, MD 20857
Public Health Rep 103:242-5. 1988..worked with other authorities to move against quack AIDS products and to educate the public concerning this health fraud.FDA hopes that through all these efforts it can help researchers in government, academia, and industry advance the ..
- Changing social policy: Grassroots to legislationLiz Lemiska
Middlesex Hospital, Middletown, Connecticut, USA
J Wound Ostomy Continence Nurs 29:149-63. 2002..vie to get the most for their health care dollars, federal and state governments attempt to mediate, prevent fraud and abuse, and protect all parties involved...
- Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and TutorialM R Melamed
Department of Pathology, New York Medical College, Valhalla 10595, USA
Acta Cytol 42:69-75. 1998..the medical profession itself, which must recognize the following: (a) Resources are finite; (b) Elimination of fraud, abuse and waste is not enough to bring health care expenditures down to levels considered acceptable to ..
- Interventional pain management at crossroads: the perfect storm brewing for a new decade of challengesLaxmaiah Manchikanti
Pain Management Center of Paducah, Paducah, KY, USA
Pain Physician 13:E111-40. 2010..Numerous factors contribute to increasing health care costs. They include administrative costs, waste, abuse, and fraud. It has been claimed the U.S. health care system wastes up to $800 billion a year...
- Neonatal jaundice and scientific fraud in 1804T W R Hansen
Department of Pediatrics, Rikshospitalet, University of Oslo, Norway
Acta Paediatr 91:1135-8. 2002..Unfortunately, university records from that period are incomplete, and it is not clear what, if anything, was done about the matter. Baumes had a very distinguished career and achieved a great reputation as both a teacher and clinician...
- Clinical forensic medicine and its main fields of activity from the foundation of the German Society of Legal Medicine until todayS Pollak
Institute of Legal Medicine, University of Freiburg, Albertstrasse 9, Freiburg D 79104, Germany
Forensic Sci Int 144:269-83. 2004..was typically to evade military service, this category of injury was later mainly seen in the context of insurance fraud; more recently most forensically relevant self-inflicted injuries refer to simulated offenses (fictitious sexual ..
- Ethical and quasi-ethical issues in medical editing and publishingR M Pitkin
Obstetrics and Gynecology, 10921 Wilshire Boulevard, Suite 403, Los Angeles, CA 90024 3908, USA
Croat Med J 39:95-101. 1998..When fraud or plagiarism is alleged about something a journal has published, the journal is not equipped to undertake the ..
- A Compact and Low Cost High-Precision Carbon Isotope Ratio Monitoring Tool for RoNabil Saad; Fiscal Year: 2009..authentication and controls in place to ensure the safety and integrity of food, the consumer is at risk of fraud and its sometimes disastrous effects on the health and welfare of the general public...
- Environmental factors predictive of misbehavior in collaborative health researchJames M DuBois; Fiscal Year: 2010..g., we will not focus just on fraud or narrow misconduct cases), and cases involving differing levels of collaboration...
- SOUTH AFRICA RESEARCH ETHICS CAPACITY BUILDING PROJECTSolomon Benatar; Fiscal Year: 2001..of international research activities, (VII) the need for international vaccine trials, and (VIII) recent research fraud in SA...
- SOCIAL INFLUENCE ON MEMORY ACROSS THE ADULT LIFESPANColleen Kelley; Fiscal Year: 1999..memory responses, people may experience negative consequences including increased vulnerability to deception and fraud. This could be particularly problematic for older adults who experience more memory failures or are less confident ..
- Quality Assurance and Data Integrity in Clinical TrialsYuan I Min; Fiscal Year: 2002..is to examine current practices, expert opinions, and case studies to develop statistical approaches for detecting fraud and to develop guidelines for the prevention and detection of fraud in clinical trials...
- Michigan Health Fraud Task ForceEllen Marks; Fiscal Year: 2005..Abstract Not Provided. ..
- Puerto Rico Health Fraud Task ForceSANDRA TORRES RIVERA; Fiscal Year: 2005..Abstract Not Provided ..
- Use of Claims Data to Study Quality of Cancer CareJames Goodwin; Fiscal Year: 2007..We will then explore the reliability of the provider-level data in order to assess its potential utility in assessing quality of care for individual providers. ..
- Assessing Treatment-Related Harms in Prostate CancerH Welch; Fiscal Year: 2007..The entire process will be repeated on a cohort of men who receive a transurethral resection of the prostate. ..
- SYRINGE ACCESS AND HIV RISKMerrill Singer; Fiscal Year: 2002..g., high or low availability of sterile syringes) and actual risk factors (e.g., frequency of infected syringes in circulation). ..
- VARIATIONS IN BREAST CANCER TREATMENT AND MORTALITYJames Goodwin; Fiscal Year: 2002..abstract_text> ..
- Melanoma ChemopreventionRobert Dellavalle; Fiscal Year: 2006..His current career goals are completing a Masters of Science in Public Health and becoming an independent researcher in skin cancer prevention and control. ..
- UTMB Center for Population Health and Health DisparitiesJames Goodwin; Fiscal Year: 2008..unreadable] [unreadable]..
- EFFECTS OF PARTNER VIOLENCE VICTIMIZATION IN DRUG USEMerrill Singer; Fiscal Year: 2002....